Innovative medical management with resection for successful treatment of pulmonary mucormycosis despite diagnostic delay

J La State Med Soc. 2002 Mar-Apr;154(2):82-5.


We present a case of primary pulmonary mucormycosis infection in a renal transplant recipient diagnosed serendipitously by computed tomography scan. Treatment included discontinuation of immunosuppressive regimen, initiation of antifungal therapy with amphotericin B lipid complex, administration of granulocyte-macrophage colony stimulating factor, surgical excision of the involved lobe, and outpatient treatment with amphotericin B with dialysis. The patient ultimately required transplant nephrectomy as a result of immunosuppression discontinuation.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunosuppressive Agents
  • Kidney Transplantation
  • Lung Diseases, Fungal / complications
  • Lung Diseases, Fungal / diagnostic imaging
  • Lung Diseases, Fungal / therapy*
  • Middle Aged
  • Mucormycosis / complications
  • Mucormycosis / diagnostic imaging
  • Mucormycosis / therapy*
  • Pneumonectomy*
  • Radiography


  • Antifungal Agents
  • Immunosuppressive Agents
  • Amphotericin B
  • Granulocyte-Macrophage Colony-Stimulating Factor